Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients

NCT00002174 is registered in ClinicalTrials.gov with Louisiana State University Health Sciences Center in New Orleans as lead sponsor.

NCT NCT00002174
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002174 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients
Lead sponsor
Louisiana State University Health Sciences Center in New Orleans
Phase
Not applicable
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections